CaliberCos Inc.

Quotes on CaliberCos Inc., which invests in real estate, <a href="https://finance.yahoo.com/quote/CWD/">plummeted</a> more than 33% yesterday, April 17, before paring some of the losses in after-hours trading. The plunge was triggered by the announced terms of a $900,000 stock offering, which was priced at a steep discount, signaling an urgent need for capital and potential dilution for existing shareholders.

Real estate investor CaliberCos loses third of market value after public offering

VolitionRx Limited

One in nine men and one in 12 women die of cancer each year, according to <a href="https://www.who.int/ru/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services">estimates</a> by the International Agency for Research on Cancer. A frequent contributing factor, VolitionRx believes, is difficulties and delays with diagnosis. The small-cap company is <a href="https://ir.volition.com/news-events/press-releases/detail/834/volitions-nu-q-cancer-diagnostics-test-aims-to-disrupt-the-multi-billion-dollar-liquid-biopsy-industry">developing</a> a simple test that could detect cancer using just a few drops of blood. This makes analysts <a href="https://www.marketwatch.com/investing/stock/vnrx/analystestimates?mod=mw_quote_tab">bullish</a> on its stock, which is seen as offering almost 500% upside.

VolitionRx, maker of cancer blood test, could have upside of 500%


Advance Auto Parts, Inc.

Heart Test Laboratories, Inc.

Bio-Techne Corporation

Portfolio managers of multiple funds within Royce Investment Partners, the firm founded by <a href="https://kz.kursiv.media/2024-08-15/mrdr-royce/?ysclid=m18w5gmllb147978577">Wall Street legend</a> Chuck Royce, have <a href="https://www.royceinvest.com/insights/2025/2Q25/small-cap-investing-in-the-bear-market">highlighted</a> six small caps to buy during a bear market. Some of them are poised to benefit from the tariffs imposed by the Trump administration, while others are likely to be merely unaffected by them.

Royce spotlights small caps to invest in during a bear market

Comstock Inc.

Shares of Comstock, a small-cap emerging technology and materials company, <a href="https://www.marketwatch.com/investing/stock/lode">jumped</a> more than 11% yesterday, April 16. The company <a href="https://comstock.inc/press-release/comstock-metals-and-rwe-clean-energy-enter-strategic-solar-recycling-partnership/">announced</a> it will become the “preferred strategic partner” of the U.S. subsidiary of energy giant RWE, recycling expired solar panels.

Comstock to recycle solar panels for energy giant RWE; shares surge

MIRA Pharmaceuticals, Inc.

Quotes on MIRA Pharmaceuticals, a developer of treatments for neurological and neuropsychiatric disorders, <a href="https://finance.yahoo.com/quote/MIRA/">jumped</a> almost 20% yesterday, April 16, before giving back some of the gains in after-hours trading. The surge came after the company reported positive animal trial results of its drug candidate for diabetic neuropathy, a condition in which nerves are damaged due to high blood sugar levels.

MIRA Pharmaceuticals jumps 20% on successful trial of ketamine analog


D-Wave Quantum Inc.

IonQ, Inc.

International Business Machines Corporation

The Motley Fool has <a href="https://www.fool.com/investing/2025/04/15/want-to-invest-in-quantum-computing-3-stocks-that/">spotlighted</a> three stocks for investors interested in quantum computing. The picks vary in size — from the small-cap D-Wave to tech giant IBM — but the investing news and analysis outlet believes all three could deliver solid long-term returns.

The Motley Fool spotlights three quantum computing stocks

Longevity Health Holdings Inc.

Shares of Longevity Health Holdings, a <a href="https://last10k.com/sec-filings/xage#item_1_business:~:text=%D1%83%20%D0%BD%D0%B0%D1%81%20%D0%B5%D1%81%D1%82%D1%8C%20%D0%B4%D0%B2%D0%B5%20%D0%BA%D0%BE%D1%81%D0%BC%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5%20%D0%BB%D0%B8%D0%BD%D0%B8%D0%B8%20%D0%BF%D1%80%D0%BE%D0%B4%D1%83%D0%BA%D1%82%D0%BE%D0%B2%2C">maker</a> of regenerative skin care products, <a href="https://finance.yahoo.com/chart/XAGE#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">fell</a> nearly 13% yesterday, April 15, following a 67% surge the previous day. The rally was triggered by an <a href="https://www.globenewswire.com/news-release/2025/04/14/3060883/0/en/Longevity-Health-Holdings-Announces-Execution-of-Merger-Agreement-With-20-20-Biolabs.html">announced</a> merger with diagnostic test provider 20/20 BioLabs. Noble Capital Markets <a href="https://www.channelchek.com/news-channel/longevity-health-merges-with-20-20-biolabs-in-bid-to-redefine-healthy-aging">points out</a> that this is neither Longevity’s first nor likely last deal as it positions itself as a “unique micro-cap consolidator” in the rapidly growing longevity space.

Longevity Health slips after big rally triggered by merger announcement


Lisata Therapeutics, Inc.

Novo Nordisk A/S

Quotes on Lisata Therapeutics, a pharmaceutical company developing therapies to combat tumors, <a href="https://finance.yahoo.com/quote/LSTA/">gained</a> more than 10% yesterday, April 15, after it announced a partnership with one of the largest industry manufacturers, Catalent, to evaluate the efficacy of a promising Lisata therapy. Since December, Catalent has been owned by Novo Holdings, the controlling shareholder of Denmark’s Novo Nordisk, a global leader in weight-loss medications.

Biotech small cap Lisata Therapeutics jumps 10% on partnership with Novo subsidiary


Data

SolarBank Corporation

SolarBank Corporation, a Canada-based but U.S.-listed micro-cap developer of renewable and clean energy projects, is significantly undervalued, Zacks Small-Cap Research (Zacks SCR) <a href="https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_04112025_SUUN_Lantier.pdf">believes</a>, with the shares worth more than double their current market quotes. Thanks to a sizable project pipeline and continued demand for solar energy, even the shift in U.S. federal energy policy under Trump is unlikely to derail SolarBank’s growth, Zacks SCR <a href="https://scr.zacks.com/news/news-details/2025/SUUN-The-future-is-bright-Initiating-coverage-of-an-emerging-solar-developer-and-power-producer-article/default.aspx">argues</a>.

Zacks thinks micro cap SolarBank could double in price


Verve Therapeutics, Inc.

Shares of Verve Therapeutics, a biotech small cap specializing in gene-editing medicines to treat cardiovascular disease, <a href="https://finance.yahoo.com/quote/VERV/">surged</a> more than 26% yesterday, April 14, after the company reported positive early trial results for its therapy for high cholesterol.

Verve Therapeutics reports good early test results for cholesterol drug, shares soar

NuScale Power Corporation

Plug Power Inc.

CleanSpark, Inc.

The Motley Fool has <a href="https://www.fool.com/investing/2025/04/13/the-smartest-renewable-energy-stocks-to-buy-with/">highlighted</a> three small-cap stocks in the renewable energy sector for investors to buy right now. All three are speculative investments but could grow if the companies scale up their businesses. Moreover, these stocks have not been immune to the recent slump triggered by President Trump’s pro-fossil fuel <a href="https://oninvest.com/article/tramp-protiv-zelenoj-energetiki-cto-delat-investoram-v-small-cap-kompanii">stance</a>, which, according to the Motley Fool, might represent a “golden buying opportunity” for long-term investors.

The Motley Fool spotlights three ‘green’ small caps to buy on the dip


Saga Communications, Inc.

Noble Capital Markets <a href="https://www.channelchek.com/news-channel/saga-communications-sga-is-it-time-to-buy-the-stock">thinks</a> now may be the right time for investors to take a look at small-cap broadcast company Saga Communications, which operates more than a hundred radio stations globally. The stock has <a href="https://finance.yahoo.com/quote/SGA/">dropped</a> nearly 50% over the last year, largely due to macroeconomic uncertainty weighing on ad revenues. However, Noble believes the company can now get back to focusing on strategy execution.

Noble cuts target price, maintains ‘outperform’ on Saga Coms. as shares slide

Last week, small caps were the worst-performing segment of the U.S. market, while volatility reached staggering levels — 3.5 times the five-year average. Here's a recap of what happened in the space between April 7 and April 11, and what to expect in the week ahead.

Small-cap recap/preview: Underperformance, extreme volatility, 30 firms to report

Small Caps

Important news and analysis of global markets: stocks, crypto, bonds, ETF